Acute Ischaemic Stroke Clinical Trial
A Randomised, Double-Blind, Placebo-Controlled, International, Multicentre, Phase III Study to Investigate the Efficacy and Safety of Ticagrelor and ASA Compared With ASA in the Prevention of Stroke and Death in Patients With Acute Ischaemic Stroke or Transient Ischaemic Attack
|Contact||AstraZeneca Clinical Study Information Center|
|Status||Not yet recruiting|
|Start date||January 31, 2018|
|Completion date||December 16, 2019|
Study to investigate if the study drug ticagrelor and ASA is more effective than Placebo (inactive tablet) and ASA in preventing new stroke events.
||Phase 2/Phase 3|